DA-1241

· NeuroBo Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DA-1241, covering 2017-11-20 to 2024-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH [Phase 2]